| |
| |
|
| Insider
Information: |
Slakter Jason Scott |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,067,898 |
|
|
Indirect Shares
|
1,195,724 |
|
|
| Direct
Value |
$5,755,970 |
|
|
|
Indirect Value
|
$6,444,952 |
|
|
| Total
Shares |
2,263,622 |
|
|
| Total
Value |
$12,200,923 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neubase Therapeutics Ord Shs |
NBSE |
Chief Executive Office... |
2017-04-10 |
1,067,898 |
2017-04-10 |
1,195,724 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2017-04-10 |
4 |
B |
$0.70 |
$100,001 |
D/D |
142,858 |
1,067,898 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-07-18 |
4 |
A |
$0.00 |
$0 |
I/I |
497,859 |
1,195,724 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-06-20 |
4 |
B |
$2.71 |
$25,000 |
D/D |
8,786 |
925,040 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
B |
$3.09 |
$11,447 |
D/D |
3,682 |
916,254 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-05-24 |
4 |
B |
$3.06 |
$23,178 |
D/D |
7,503 |
912,572 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-05-23 |
4 |
B |
$3.11 |
$65,199 |
D/D |
20,565 |
905,069 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-04-11 |
4 |
B |
$3.35 |
$20,938 |
D/D |
6,250 |
884,504 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-03-07 |
4 |
B |
$3.41 |
$22,669 |
D/D |
6,250 |
878,254 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-02-22 |
4 |
B |
$3.06 |
$19,432 |
D/D |
6,250 |
872,004 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-01-19 |
4 |
B |
$3.52 |
$22,606 |
D/D |
6,250 |
865,754 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
350,358 |
859,504 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2015-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
497,859 |
697,865 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2015-12-07 |
4 |
AB |
$4.00 |
$12,219 |
D/D |
3,000 |
509,146 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2015-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
428,223 |
506,146 |
0 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2015-11-03 |
4 |
B |
$3.01 |
$301 |
D/D |
100 |
77,923 |
2.73 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2015-11-02 |
4 |
B |
$2.97 |
$39,738 |
D/D |
13,250 |
77,823 |
2.81 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Director |
– • – |
2015-02-06 |
4 |
B |
$6.75 |
$200,003 |
D/D |
29,630 |
64,573 |
2.39 |
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Director |
– • – |
2015-01-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,943 |
|
- |
|
| NBSE |
Neubase Therapeutics Ord ... |
Director |
– • – |
2015-01-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
425,505 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
